Though HER2 plays an oncogenic role in many cancers [9, 25, 34], we observed an increased rate of proliferation in the HER2 knockdown cells as compared to scrambled control CD18/HPAF and Capan-1 cells by performing growth kinetics assay (Figure 4A and Supplementary Figure 3). The gene discussed is ITGB2; the disease is cancer.